MMNBX | RMFCX | MMNBX / RMFCX | |
Total Expense Ratio | 0.74 | 0.91 | 81% |
Annual Report Gross Expense Ratio | 0.74 | 0.91 | 81% |
Fund Existence | 2 years | 23 years | - |
Gain YTD | 7.106 | 9.596 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 250 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 338M | 108B | 0% |
Annual Yield % from dividends | 1.73 | 1.27 | 137% |
Returns for 1 year | -15.88 | 11.47 | -138% |
Returns for 3 years | N/A | 29.27 | - |
Returns for 5 years | N/A | 61.83 | - |
Returns for 10 years | N/A | 79.21 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GAFFX | 82.92 | 0.81 | +0.99% |
American Funds Growth Fund of Amer F3 | |||
DCEMX | 13.94 | N/A | N/A |
Dunham Emerging Markets Stock C | |||
IIIIX | 13.08 | N/A | N/A |
Voya International Index Port I | |||
WFTCX | 5.16 | N/A | N/A |
Allspring Innovation Fund - Class C | |||
JFNIX | 66.23 | N/A | N/A |
Janus Henderson Global Life Sciences I |